Predicting and Overcoming Resistance to Immunotherapy in Pediatric High-Grade Glioma |
Ann & Robert H. Lurie Children’s Hospital of Chicago / Oren Becher, MD & Robert Wechsler-Reya, PhD |
Innovation Grants |
2019 |
Illinois |
Genome-Wide 5hmC Profiling of Neuroblastoma Tumors and Patient Cell-Free DNA |
University of Chicago / Susan Cohn, MD & Chuan He PhD |
Innovation Grants |
2017 |
Illinois |
Therapeutic Targeting of Childhood Leukemia by Pharmacological Inhibition of Proteolytic Cleavage of MLL1 |
Northwestern University (Illinois) / Zibo Zhao, PhD |
Young Investigator Grants |
2018 |
Illinois |
Racial and Ethnic Disparities in Survival of Children with Neuroblastoma |
University of Chicago / Susan Cohn, MD |
Innovation Grants |
2011 |
Illinois |
Theranostics in Children and Young Adults |
University of Iowa / Sue O'Dorisio, MD, PhD |
Springboard Grants |
2013 |
Iowa |
Molecular Mechanism and Development of Therapeutic Strategies Targeting MYCN-induced Calcium Signaling in Advanced Neuroblastoma |
University of Hawaii at Hilo / Ingo Koomoa-Lange, PhD |
Young Investigator Grants |
2014 |
Hawaii |
DFMO-based combination therapy for the treatment of advanced stage neuroblastoma.
|
Cancer Research Center of Hawaii / Dana-Lynn Koomoa |
Young Investigator Grants |
2009 |
Hawaii |
Phase I Trial of Indoximod in Combination with Temozolomide-based Therapy for Children with Progressive Primary Brain Tumors |
Georgia Health Sciences University Research Institute, Inc. / Theodore Johnson, M.D., Ph.D. |
Bio-Therapeutic Impact Award |
2014 |
Georgia |
The Role of LIN28B-let-7-PBK Axis on the Growth and Metastasis of Group 3 Medulloblastoma |
Emory University / Shubin Shahab, MD/PhD |
Young Investigator Grants |
2021 |
Georgia |
PI-3 kinase as a novel and attractive target in pediatric cancer and neuroblastoma
|
Emory University / Donald Durden |
Innovation Grants |
2008 |
Georgia |